Abstract Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and
social impact for which multiple conventional and novel pharmacotherapies are currently …

Purpose Cardiac autonomic neuropathy (CAN) is a serious complication of type 1 and type 2
diabetes and is independently associated with major cardiovascular events, morbidity, and …

Background Sodium–glucose transporter 2 inhibitors (SGLT2-I) could modulate
atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to …

Background Sodium-glucose co-transporter 2 inhibitors (SGLT2-i) have shown significant
cardiovascular benefits in patients with and without type 2 diabetes mellitus (T2DM). They …

Cardiovascular autonomic neuropathy (CAN) is an under-recognised yet highly prevalent
microvascular complication of diabetes. CAN affects approximately 20% of people with …

Type 2 diabetes is associated with a higher risk of cardiac arrhythmias, especially in
presence of cardiovascular disease and/or heart failure. Even if atrial fibrillation/flutter …

Aims and data synthesis Glucose variability (GV) is increasingly considered an additional
index of glycemic control. Growing evidence indicates that GV is associated with diabetic …

Pulse wave velocity (PWV) has been established as a promising biomarker in
cardiovascular diagnostics, providing deep insights into vascular health and cardiovascular …

Diabetes mellitus (DM) and heart failure (HF) are frequently encountered afflictions that are
linked by a common pathophysiologic background. According to landmark studies, those …

Syncope is a highly prevalent clinical condition characterized by a rapid, complete, and brief
loss of consciousness, followed by full recovery caused by cerebral hypoperfusion. This …